Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.
|
26831199 |
2016 |
Creatinine measurement, serum (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.
|
26831199 |
2016 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genetic determinants influencing human serum metabolome among African Americans.
|
24625756 |
2014 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate.
|
23535967 |
2013 |
Chronic Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide association and functional follow-up reveals new loci for kidney function.
|
22479191 |
2012 |
Kidney Failure, Chronic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
New loci associated with kidney function and chronic kidney disease.
|
20383146 |
2010 |
Creatinine measurement, serum (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New loci associated with kidney function and chronic kidney disease.
|
20383146 |
2010 |
Chronic Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
GWASDB |
New loci associated with kidney function and chronic kidney disease.
|
20383146 |
2010 |
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The cellular levels of β-site APP cleaving enzyme 1 (BACE1), the rate-limiting enzyme for the generation of the Alzheimer disease (AD) amyloid β-peptide (Aβ), are tightly regulated by two ER-based acetyl-CoA:lysine acetyltransferases, ATase1 and ATase2.
|
22267734 |
2012 |
Vascular calcification
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Concurrently, the loss of smooth-muscle lineage markers and matrix gamma-carboxyglutamic acid (Gla) protein (cMGP) in aortas was ameliorated by administering IMD to rats with VC, and the increased phosphor-Smad(1/5/8) and core binding factor alpha-1 levels in calcified vasculature were also reduced.
|
19910445 |
2010 |
Hypertensive disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The diversity of NAT8 5' upstream region (pi/bp = 0.00320) exceeded up to 10 times the variation in the NAT8 genic region (pi/bp = 0.00037) as well as the average variation (pi/bp = 0.00040) for the promoters of 29 reference genes associated with hypertension.
|
18402670 |
2008 |
Kidney Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The NAT8 promoter SNPs were targeted with pilot quantitative association studies for blood pressure (n = 137, healthy unrelated individuals) and for the index of kidney function - estimated glomerular filtration rate (eGFR; n = 157 hypertensives with and without nephropathy).
|
18402670 |
2008 |